ARCHIVES

Early HER2 Positive Patients At Higher Risk of Recurrence

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

Manipulating The Therapeutic Index Clinical Trials Goal: Hellman

June 13, 1980

General Says HHS Shift of Breast Cancer funds Could Leave Army in “Untenable Position”

March 12, 1993

Group Urges U.S., USSR Exchange In Surgical Oncology

January 6, 1989

Breast Cancer Vs. Other Cancers In Budget Showdown

July 3, 1992

Jane Henney Said Tentative Choice For FDA Commissioner

May 22, 1998